Author Archives: Patient Advocate

December 21 2022, BioNTech announced they had dosed the first clinical trial participant. This is the first-in-human study aims to evaluate the safety and immunogenicity of prophylactic herpes virus vaccine candidate BNT163. Company statement; “We aim to help address diseases with a high unmet medical need and of global health relevance, and we are combiningContinue reading “BioNTech New Clinical Trial for Herpes Vaccine begins”

How to get tested for Herpes Testing for herpes is complicated and can be confusing in America. Currently available, FDA-approved IgG antibody tests sometimes present with false positive results where the test says you are infected with HSV and you are not. Tests can also have false negative results. Most often, false positive results areContinue reading “Testing for Herpes: Step-by-Step Guide”

We lost our baby to neonatal herpes, and her life mattered. Our daughter would be turning a year old this coming September 2022. Instead of celebrating her birth, though, we will be gathering to memorialize her 27 days of life. Our daughter died a horrible death due to acquiring HSV-2 in the birth canal, alsoContinue reading “We lost our baby daughter to neonatal herpes”

Herpes Cure Advocacy celebrates and thanks the US House of Representatives for their prioritization of federal action for Herpes Simplex Virus cure, treatment and prevention in the FY 2023 House budget report. In the house budget report for FY 2023, published on June 29, there is report language that directs NIH to assemble a multi-councilContinue reading “Important Win for Herpes Advocacy: FY 2023 Congress Budget Update”

Chinese company BDGene from Shanghai continues to lead in the global race for a herpes keratitis cure. The highly anticipated treatment, BD111 has reached a big milestone as it applied for Orphan Drug designation from the US FDA. Previously, BD111 has received international attention for its progress with a gene editing cure for herpes keratitis.Continue reading “Possible herpes keratitis cure takes another step: BDGene of China applies for Orphan Drug Designation at the FDA”

The BioNTech team and UPenn have previously partnered on pre-clinical study of an mRNA-based vaccine candidate to prevent genital herpes. This work is led by lead investigator Dr. Harvey Friedman and team at the University of Pennsylvania. A new clinical trial A Clinical Trial in Healthy Volunteers to Study the Safety, Tolerability, and Immune ResponsesContinue reading “New Clinical Trial for Herpes Vaccine from Biontech + UPenn”

GlaxoSmithKline Pipeline Update GSK has officially updated its clinical research pipeline to include a vaccine for HSV-2! Their therapeutic vaccine for HSV-2 isn’t mRNA (or what they called SAM technology) but an adjuvanted therapeutic vaccine. The trial (currently recruiting) is a Phase 1/2 combined trial that ends in 2024. GSK will test 9 different formulationsContinue reading “New Clinical Trial for Herpes Simplex Virus”

Herpes Cure Advocacy is excited to announce we are pursuing filing as a non-profit organization with 501c3 status. Herpes Cure Advocacy is launching a small capital campaign to raise $25,000 – these funds will allow us to further our work to advance the treatment and prevention of Herpes Simplex Virus types 1 and 2 inContinue reading “Fundraising begins for a Herpes Cure”